The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure

AIMS: No studies have comprehensively compared the efficacy of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors, renin–angiotensin system (RAS) inhibitors, and angiotensin receptor neprilysin (ARN) inhibitors based on different type of heart failure, including heart failure with reduced ejection fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Peng‐juan, Zhang, Zhuo‐ya, Yan, Qi, Cao, Hui‐li, Zhao, Ya‐jing, Yang, Bin, Li, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053170/
https://www.ncbi.nlm.nih.gov/pubmed/36722326
http://dx.doi.org/10.1002/ehf2.14298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053170/
https://www.ncbi.nlm.nih.gov/pubmed/36722326
http://dx.doi.org/10.1002/ehf2.14298

Ejemplares similares